- Home
- TWIN vs PALI Comparison
TWIN vs PALI Comparison
Compare TWIN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | PALI |
|---|---|---|
| Founded | 1918 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 240.2M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TWIN | PALI |
|---|---|---|
| Price | $17.61 | $1.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $12.00 | ★ $13.00 |
| AVG Volume (30 Days) | 53.9K | ★ 3.5M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.53 | N/A |
| Revenue | ★ $340,738,000.00 | $260,000.00 |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $11.73 | ★ N/A |
| Revenue Growth | 15.45 | ★ 1500.39 |
| 52 Week Low | $6.16 | $0.55 |
| 52 Week High | $19.63 | $2.64 |
Technical Indicators
Market Signals| Indicator | TWIN | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 54.21 |
| Support Level | $14.95 | $1.58 |
| Resistance Level | $18.91 | $1.93 |
| Average True Range (ATR) | 1.04 | 0.13 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 46.84 | 77.38 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.